Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Men Yuan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Virchows Archiv : an International Journal of Pathology|February 24, 2025
FOXA1 expression and its association with mucin expression and KRAS mutation in ovarian mucinous tumors: implications for tumor progression and differentiationMen Yuan, Harumi Saeki, Takuo Hayashi, et al.
International Journal of Surgical Pathology|May 9, 2023
Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the BreastMen Yuan, Harumi Saeki, Yoshiya Horimoto, et al.
Annals of Surgical Oncology|June 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant ChemotherapyYuko Ueki, Yoshiya Horimoto, Men Yuan, et al.
Scientific Reports|December 31, 2024
Characterization of breast cancer tumors in older patients who show de novo resistance to endocrine therapyYumiko Ishizuka, Yoshiya Horimoto, Men Yuan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Virchows Archiv : an International Journal of Pathology|February 24, 2025
FOXA1 expression and its association with mucin expression and KRAS mutation in ovarian mucinous tumors: implications for tumor progression and differentiationMen Yuan, Harumi Saeki, Takuo Hayashi, et al.
International Journal of Surgical Pathology|May 9, 2023
Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the BreastMen Yuan, Harumi Saeki, Yoshiya Horimoto, et al.
Annals of Surgical Oncology|June 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant ChemotherapyYuko Ueki, Yoshiya Horimoto, Men Yuan, et al.
Scientific Reports|December 31, 2024
Characterization of breast cancer tumors in older patients who show de novo resistance to endocrine therapyYumiko Ishizuka, Yoshiya Horimoto, Men Yuan, et al.
Pageof 1